MIR664B
gene geneOn this page
Also known as hsa-mir-664b
Summary
MIR664B (microRNA 664b, HGNC:43501) is a microRNA gene on chromosome Xq28.
microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.
Source: NCBI Gene 100847052 — RefSeq curated summary.
At a glance
- Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:43501 |
| Approved symbol | MIR664B |
| Name | microRNA 664b |
| Location | Xq28 |
| Locus type | RNA, micro |
| Status | Approved |
| Aliases | hsa-mir-664b |
| Ensembl gene | ENSG00000284450 |
| Ensembl biotype | miRNA |
| Entrez | 100847052 |
| RNAcentral | URS000075DD29 — ncRNA, 61 nt, 4 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 miRNA
ENST00000626756
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000626756 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003766657 | 154768596 | 154768656 |
Expression profiles
Bgee: expression breadth broad, 11 present calls, max score 68.95.
Top tissues by expression
11 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| zone of skin | UBERON:0000014 | 68.95 | gold quality |
| caudate nucleus | UBERON:0001873 | 68.83 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 68.56 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 67.11 | gold quality |
| skin of abdomen | UBERON:0001416 | 66.04 | gold quality |
| esophagus mucosa | UBERON:0002469 | 64.47 | gold quality |
| amygdala | UBERON:0001876 | 64.33 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 63.57 | gold quality |
| tibial nerve | UBERON:0001323 | 61.49 | gold quality |
| omental fat pad | UBERON:0010414 | 60.24 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 55.78 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 7)
- miR-664 functions as an oncogene miRNA and has an important role in promoting human osteosarcoma cell proliferation by suppressing FOXO4 expression. (PMID:26463624)
- miR-664 was remarkably high in cutaneous squamous cell carcinomas (cSCC) patient specimens and cSCC cell lines. Study identified IRF2 as a direct downstream target of miR-664. Knockdown of IRF2 reverses pro-tumorigenesis phenotype of miR-664; whereas IRF2 over-expression inhibits miR-664 tumorigenesis in cSCC. Together, it revealed miR-664 functions as an oncogene in cSCC via suppression of IRF2. (PMID:31138473)
- miR-664b-5p Inhibits Hepatocellular Cancer Cell Proliferation Through Targeting Oncogene AKT2. (PMID:31967930)
- lncRNA RASSF8AS1 suppresses the progression of laryngeal squamous cell carcinoma via targeting the miR664b3p/TLE1 axis. (PMID:33000257)
- Downregulation of ARMC8 promotes tumorigenesis through activating Wnt/beta-catenin pathway and EMT in cutaneous squamous cell carcinomas. (PMID:34016486)
- miR-664b-3p inhibits colon cell carcinoma via negatively regulating Budding uninhibited by benzimidazole 3. (PMID:35156516)
- Long noncoding RNA HOXD-AS1 promotes the progression of pancreatic cancer through miR-664b-3p/PLAC8 axis. (PMID:35279480)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.